1. Home
  2. CLDI vs GTIM Comparison

CLDI vs GTIM Comparison

Compare CLDI & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDI
  • GTIM
  • Stock Information
  • Founded
  • CLDI 2014
  • GTIM 1987
  • Country
  • CLDI United States
  • GTIM United States
  • Employees
  • CLDI N/A
  • GTIM N/A
  • Industry
  • CLDI Biotechnology: Biological Products (No Diagnostic Substances)
  • GTIM Restaurants
  • Sector
  • CLDI Health Care
  • GTIM Consumer Discretionary
  • Exchange
  • CLDI Nasdaq
  • GTIM Nasdaq
  • Market Cap
  • CLDI 20.2M
  • GTIM 17.1M
  • IPO Year
  • CLDI N/A
  • GTIM 1990
  • Fundamental
  • Price
  • CLDI $1.76
  • GTIM $1.73
  • Analyst Decision
  • CLDI
  • GTIM
  • Analyst Count
  • CLDI 0
  • GTIM 0
  • Target Price
  • CLDI N/A
  • GTIM N/A
  • AVG Volume (30 Days)
  • CLDI 1.1M
  • GTIM 34.9K
  • Earning Date
  • CLDI 08-08-2025
  • GTIM 08-07-2025
  • Dividend Yield
  • CLDI N/A
  • GTIM N/A
  • EPS Growth
  • CLDI N/A
  • GTIM 17.03
  • EPS
  • CLDI N/A
  • GTIM 0.12
  • Revenue
  • CLDI N/A
  • GTIM $143,398,000.00
  • Revenue This Year
  • CLDI N/A
  • GTIM N/A
  • Revenue Next Year
  • CLDI N/A
  • GTIM N/A
  • P/E Ratio
  • CLDI N/A
  • GTIM $14.67
  • Revenue Growth
  • CLDI N/A
  • GTIM 1.78
  • 52 Week Low
  • CLDI $1.61
  • GTIM $1.34
  • 52 Week High
  • CLDI $46.68
  • GTIM $3.45
  • Technical
  • Relative Strength Index (RSI)
  • CLDI 29.56
  • GTIM 59.37
  • Support Level
  • CLDI $1.61
  • GTIM $1.69
  • Resistance Level
  • CLDI $6.06
  • GTIM $1.84
  • Average True Range (ATR)
  • CLDI 0.77
  • GTIM 0.10
  • MACD
  • CLDI -0.55
  • GTIM 0.03
  • Stochastic Oscillator
  • CLDI 2.57
  • GTIM 78.00

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

About GTIM Good Times Restaurants Inc.

Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.

Share on Social Networks: